IRIS
TABATON, MASSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 16.456
Totale 16.456
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 16.456
Totale 16.456
Salva come PNG Salva come JPEG
Città #
Genova 12.792
Rapallo 1.513
Genoa 1.101
Vado Ligure 996
Bordighera 54
Totale 16.456
Salva come PNG Salva come JPEG
Nome #
Monomeric Aβ1-42 and RAGE: key players in neuronal differentiation 168
A novel presenilin 1 L166H mutation in a pseudo-sporadic case of early-onset Alzheimer's disease. 148
Hereditary motor and sensory neuropathy with deafness, mental retardation and absence of large myelinated fibers. 147
17A, a novel non-coding RNA, regulates GABA B alternative splicing and signaling in response to inflammatory stimuli and in Alzheimer disease 146
Direct immunofluorescence in sural nerve biopsies. 141
Motor and sensory evoked potentials in progressive supranuclear palsy. 138
Lipoperoxidation is selectively involved in progressive supranuclear palsy 137
Survival rate in Patients affected by Dementia followed by memory clinics (UVA) in Italy 135
Amnestic mild cognitive impairment and conversion to Alzheimer's disease: insulin resistance and glycoxidation as early biomarker clusters. 135
GFAP expression of human Schwann cells in tissue culture. 134
Increase of cdk5 is related to neurofibrillary pathology in progressive supranuclear palsy 133
JNK and ERK1/2 pathways have a dual opposite effect on the expression of BACE1. 133
Balance features in Alzheimer's disease and amnestic mild cognitive impairment 130
Early glycoxidation damage in brains from Down’s syndrome 130
Possible Influence of a Non-Synonymous Polymorphism Located in the NGF Precursor on Susceptibility to Late-Onset Alzheimer's Disease and Mild Cognitive Impairment 130
The increased activity of BACE1 correlates with oxidative stress in Alzheimer’s disease. 128
Position paper of the Italian Society for the study of Dementias (Sindem) on the proposal of a new Lexicon on Alzheimer disease. 128
Abnormal tau-reactive filaments in olfactory mucosa in biopsy specimens of patients with probable Alzheimer's disease. 127
Artificial neural networks identify the predictive values of risk factors on the conversion of amnestic mild cognitive impairment. 125
Oxidative stress mediates the pathogenic effect of different Alzheimer's disease risk factors. 124
Mutant presenilin 1 increases the expression and activity of BACE1. 123
Elevation of βAmyloid 1-42 Autoantibodies in the Blood of Amnestic Patients With Mild Cognitive Impairment. 123
Amyloid-β₄₂ activates the expression of BACE1 through the JNK pathway. 123
Aβ 1-42-mediated down-regulation of Uch-L1 is dependent on NF-κB activation and impaired BACE1 lysosomal degradation. 123
Protein levels of glycogen synthase 3 kinase are normal in progressive supranuclear palsy. 122
Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy 121
Frontal Variant of Alzheimer's Disease: A Report of a Novel PSEN1 Mutation 121
Oxidative damage in the olfactory system in Alzheimer’s disease. 120
RNA polymerase III drives alternative splicing of the Potassium Channel Interacting Protein contributing to brain complexity and neurodegeneration 119
Office of Rare Diseases neuropathologic criteria for corticobasal degeneration 118
Role of water-soluble amyloid-beta in the pathogenesis of Alzheimer's disease. 118
The 14-3-3 protein in multiple sclerosis: a marker of disease severity. 118
The Unexpected Role of Aβ1-42 Monomers in the Pathogenesis of Alzheimer's Disease 118
B-Amyloid 1-42 and RAGE play a key role in ATRA-induced neuronal differentiation 117
Alternative, non-secretase processing of Alzheimer’s b-amyloid precursor protein during apoptosis by Caspase-6 and-8 116
Fibroblasts from FAD-linked presenilin 1 mutations display a normal unfolded protein response but overproduce Abeta42 in response to tunicamycin 115
Upregulation of presenilin 1 in brains of sporadic, late-onset Alzheimer's disease 115
Peripheral neuropathy in Cockayne syndrome. 115
A novel origin for granulovacuolar degeneration in aging and Alzheimer's disease: parallels to stress granules 114
Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism 113
Heterogeneity of water-soluble amyloid b-peptide in Alzheimer’s disease and Down’s syndrome brains 113
Beta-amyloid 1-42 monomers, but not oligomers, produce PHF-like conformation of Tau protein 113
The H1 haplotype of the tau gene (MAPT) is associated with mild cognitive impairment 112
Microtubule reduction in Alzheimer’s disease and aging is independent of tau filament formation. 112
Beta-Site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways. 111
HLA-DR Schwann cell reactivity in peripheral neuropathies of different origins. 111
Oxidative stress induces increase in intracellular amyloid-protein production and selective activation of I and II PKCs in NT2 cells 111
AGEs/RAGE complex upregulates BACE1 via NF-κB pathway activation 111
Oxidative stress in Alzheimer disease: A possibility for prevention. 110
Demonstration of a novel neurofilament associated antigen with the neurofibrillary pathology of Alzheimer and related diseases. 110
A quantitative and ultrastructural study of substantia nigra and nucleus centralis superior in Alzheimer's disease. 109
Non traumatic dissecting aneurysm of the basilar artery 109
The Decrease of Uch-L1 Activity Is a Common Mechanism Responsible for Aβ 42 Accumulation in Alzheimer's and Vascular Disease 109
Plasma levels of insulin and amyloid beta 42 are correlated in patients with amnestic Mild Cognitive Impairment 107
Amyloid-beta42 plasma levels are elevated in amnestic mild cognitive impairment. 107
Generation of an apoptotic intracellular peptdide by g-secretase cleavage of Alzheimer’s amyliod b-protein precursor. 106
Mitochondrial abnormalities in Alzheimer disease. 106
Regulation of glycogen synthase kinase-3beta by products of lipid peroxidation in human neuroblastoma cells 106
Creutzfeldt-Jakob disease in the city and district of Genoa: estimated mortality rate in the six year period 1974-1979. 106
Amyloid-b deposition in Alzheimer transgenic mice is associated with oxidative stress. 106
The Cell Cycle Regulator Phosphorylated Retinoblastoma Protein Is Associated With Tau Pathology in Several Tauopathies 106
Microarray analysis in Alzheimer’s disease and normal aging 105
Amyloid-β Production: Major Link Between Oxidative Stress and BACE1. 105
Dual Mechanism of Toxicity for Extracellular Injection of Tau Oligomers versus Monomers in Human Tau Mice 105
Neurosyphilis presenting as a progressive supranuclear palsy 104
Increased amyloidogenic secretion in cerebellar granule cells undergoing apoptosis 104
Schwann cell GFAP expression increases in axonal neuropathies. 104
Tyrosine kinase A-Nerve Growth Factor receptor is antigenically present in dystrophic neurites from a variety of conditions but not in Alzheimer's disease. 104
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. 104
Association of a presenilin 1 S170F mutation with a novel Alzheimer disease molecular phenotype 103
Alz 50 recognizes abnormal filaments in Alzheimer's disease and progressive supranuclear palsy. 103
Relationship between Balance and Cognitive Performance in Older People 103
Oxidative stress increase expression and activity of BACE in NT2 neurons 102
Chronic oxidative stress causes increased tau phosphorylation in M17 neuroblastoma cells 102
CSF and serum IgG and albumin in schizophrenics 102
Mechanisms of phenotypic heterogeneity in prion, Alzheimer and other conformation disease. Journal Alz Disease. 101
Huntington's disease: survival of large striatal neurons in the rigid variant. 101
Italian multicenter study of dementia: a pathologically verified case of Alzheimer disease. 101
Neuronal apoptosis is accompanied by selective intracellular A-beta production and APP caspase cleavage 100
Increased expression of the normal cellular isoform of prion protein in inclusion-body myositis, inflammatory myopathies and denervation atrophy. 99
Fatal familial insomnia and the widening spectrum of prion diseases 99
A novel mechanism of phenotypic heterogeneity demonstrated by the effect of a polymorphism on a pathogenic mutation in the PRNP (prion protein gene) 99
Early myoclonus and quasiperiodic EEG changes in non-familial Alzheimer's disease. 98
Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (Progressive Supranuclear Palsy) 98
Amyloid beta protein deposition in brains from elderly subjects with leukoaraiosis. 98
Memantine: "hypothesis testing" not "disease modifying" in Alzheimer's disease. 97
Opposite role of apolipoprotein E in normal brain and Alzheimer's disease 97
The Earliest Stage of Cognitive Impairment in Transition From Normal Aging to Alzheimer Disease Is Marked by Prominent RNA Oxidation in Vulnerable Neurons. 97
Neuropil threads of Alzheimer's disease show a marked alteration of the normal cytoskeleton. 96
Oxidative stress activates a positive feedback between the gamma- and beta-secretase cleavages of the beta-amyloid precursor protein. 95
Zoster sine herpete causing encephalomyelitis. 95
Autophagocytosis of Mitochondria Is Prominent in Alzheimer Disease. 95
Neuroprotective properties of Bcl-w in Alzheimer disease. 94
Presence of soluble amyloid beta peptide precedes amyloid plaque formation in Down's syndrome 94
Influence of neuronal location on antigenic properties of neurofibrillary tangles. 93
Evidence that the Amyloid beta Precursor Protein-intracellular domain lowers the stress threshold of neurons and has a "regulated" transcriptional role 93
A silver lining for 24-hydroxycholesterol in Alzheimer's disease: The involvement of the neuroprotective enzyme sirtuin 1 93
Soluble amyloid beta-protein is increased in frontotemporal dementia with tau gene mutations. 92
Ultrastructural localization of beta-amyloid, tau, and ubiquitin epitopes in extracellular neurofibrillary tangles. 92
Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment. 92
Totale 11.239
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.275
article - articoli 42.275
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.550
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.396 0 0 0 0 0 507 682 295 419 790 477 226
2020/2021972 70 85 82 65 57 88 46 92 133 99 81 74
2021/20222.016 67 134 160 259 87 98 91 507 86 221 70 236
2022/20231.825 199 123 11 164 305 344 22 139 340 8 154 16
2023/2024769 37 133 7 88 75 89 41 80 43 8 53 115
2024/20251.075 52 202 67 159 341 254 0 0 0 0 0 0
Totale 16.536